Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
10/2005
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1058679B1 Synthesis of epothilones, intermediates thereto and analogues therof
10/19/2005EP0966446B1 Bicyclic inhibitors of protein farnesyl transferase
10/19/2005CN1685014A Metal complexes as light-absorbing compounds in the information layer of optical data carriers
10/19/2005CN1684680A Imidazole alkaloids from lepidium meyenii and methods of usage
10/19/2005CN1684678A Thiomolybdate analogues and uses thereof
10/19/2005CN1683347A Substituted aryl methylene sulfonylated aza cyclo-pentanone compounds, its medicine compositions and its preparing process and use
10/18/2005US6956988 Optical interleaver
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005US6955888 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
10/18/2005CA2340138C 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/18/2005CA2046265C Sulphured imadazole derivatives, their preparation process, the new intermediates obtained, their application as drugs and the pharmaceutical preparations containing them
10/13/2005WO2005095386A1 Substituted thiophene derivatives as anti-cancer agents
10/13/2005WO2005095356A1 Agent for generating heat or singlet oxygen and composition for cancer treatment each comprising organic peroxide or chemiluminescent compound
10/13/2005WO2005095355A1 Process for producing n,n'-carbonyldiimidazole
10/13/2005WO2005095354A1 Therapeutic agents
10/13/2005WO2005095351A1 N1 - ((pyrazol-1-ymethyl) -2-methylphenyl)- phatalamide derivatives and related compounds insecticides
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005094817A1 Melanin-concentrating hormone receptor antagonists and methods of use
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005WO2004071447A9 Substituted azole derivatives as therapeutic agents
10/13/2005US20050228201 By halogen exchange reaction using specific guanidinium, phosphonium or sulfonium catalysts, e.g., diethylaminobis[tris(diethylamino)phosphazenyl]-sulfonium bromide, diethylaminobis(tetramethyl-guanidino)sulfonium bromide and (N,N-dimethylimidazolidino)tetramethyl-guanidinium chloride
10/13/2005US20050228033 Voltage-gated sodium channel (VGSC) and prostate voltage sodium channel (PVSC) inhibitors for treating diseases characterized by overabundant or hyperactive VGSC/PVSC's; phenytoin derivatives; use as sodium channel blockers, anti-cancer agents; can be used to limit or prevent PSA growth and metastasis
10/13/2005US20050228015 Substituted heteroaryl- and phenylsulfamoyl compounds
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050227978 Fibrosis inhibitor
10/13/2005US20050227973 Human adam-10 inhibitors
10/13/2005DE102004015007A1 Substituierte Imidazole Substituted imidazoles
10/13/2005CA2562131A1 Process for producing n,n'-carbonyldiimidazole
10/13/2005CA2561977A1 Substituted thiophene derivatives as anti-cancer agents
10/13/2005CA2559005A1 Melanin-concentrating hormone receptor antagonists and methods of use
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/13/2005CA2557402A1 Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
10/12/2005EP1583746A1 A pyrazole derivative as ppar modulator
10/12/2005EP1583742A1 Novel cb 1 receptour inverse agonists
10/12/2005EP1583528A1 Nf-kb inhibitors and uses thereof
10/12/2005EP1372844A4 High activity metal carbene metathesis catalysts generated using a thermally activated n-heterocyclic carbene precursor
10/12/2005EP1202986B1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
10/12/2005CN1681804A Sulphonamide derivatives and their use as TACE inhibitors
10/12/2005CN1681490A Melanin extinguisher
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680337A Microwave radiation synthesis of 1, 3-substituted imidazole-2-thioketone
10/12/2005CN1680336A New imidazole derivative, method for producing the same and use of the same
10/12/2005CN1680335A Preparation of olmesartan medoxomill
10/12/2005CN1679491A Composition comprising at least one mixed dye based on at least one chromophore of azo or tri(hetero)arylmethane type, dyeing process and mixed dyes
10/12/2005CN1679472A Antimycotic nail varnish composition
10/11/2005US6953806 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/06/2005WO2005092865A1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
10/06/2005WO2005092864A1 Imidazole compounds for the treatment of neurodegenerative disorders
10/06/2005WO2005092845A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005WO2005092841A1 Compounds having beta-agonist activity
10/06/2005WO2005092333A1 (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
10/06/2005WO2005092332A1 (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
10/06/2005WO2005092305A2 Compounds for treating aids and other diseases
10/06/2005WO2005092066A2 Imidazole compounds
10/06/2005WO2005091697A2 Thiourea compositions and uses thereof
10/06/2005US20050222426 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine.
10/06/2005US20050222422 For wound healing in a warm blooded vertebrate
10/06/2005US20050222420 Chain oligolactic acid thioester
10/06/2005US20050222411 Method for the production of monohydro-perfluoroalkanes, bis (perfluoroalkyl) phosphinates and perfluoroalkylphosphonates
10/06/2005US20050222255 Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative
10/06/2005US20050222222 1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxo-ethylamino]-1-oxo-propyl]-4-[bis-(4-fluorophenyl)methyl]piperazine; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
10/06/2005US20050222217 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags
10/06/2005US20050222215 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
10/06/2005US20050222210 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005CA2561066A1 Antiviral 4-aminocarbonylamino-substituted imidazole compounds
10/06/2005CA2560922A1 Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
10/06/2005CA2560896A1 Imidazole compounds
10/06/2005CA2560538A1 (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
10/06/2005CA2560528A1 (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
10/06/2005CA2559035A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/05/2005EP1581516A2 3-heterocyclic benzylamide derivatives as potassium channel openers
10/05/2005EP1581507A1 Benzamide inhibitors of the p2x7 receptor
10/05/2005EP1581504A1 Process for preparing substituted imidazole derivatives and intermediates used in the process
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581470A1 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
10/05/2005CN1679200A Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery
10/05/2005CN1678395A Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions
10/05/2005CN1678315A Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
10/05/2005CN1676523A Method for preparing antihypertension losartan
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
10/04/2005US6951948 Method for synthesis of substituted azole libraries
10/04/2005US6951945 Heteroaromatic glucokinase activators
10/04/2005US6951574 Primary intermediates for oxidative coloration of hair
10/04/2005CA2190858C Intermediate for preparing a pharmaceutically active compound
09/2005
09/29/2005WO2005090316A1 HYDANTOINS HAVING RNase MODULATORY ACTIVITY
09/29/2005WO2005090315A1 Novel compounds as opioid receptor modulators
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005090292A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
1 ... 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 ... 345